All In MedTech

Device type · DHX

System, Test, Carcinoembryonic Antigen

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about DHX: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 20, 2026Source: openFDAMethods & limitations

Product code

DHX

Immunology

Device class

Class II

FDA decisions since 2015

3

510(k), De Novo and PMA

Adverse event reports

19

Received Nov 1, 2025 to Nov 20, 2026

How FDA classifies it

Device type
System, Test, Carcinoembryonic Antigen
Product code
DHX
Device class
Class II
Review panel
Immunology
Regulation
21 CFR 866.6010

Latest FDA decisions

All decisions for DHX

Reports received

19

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

19

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 240000
Feb 241000
Mar 240000
Apr 240000
May 242000
Jun 243000
Jul 241000
Aug 242000
Sep 241000
Oct 242000
Nov 241000
Dec 242000
Jan 252000
Feb 251000
Mar 251000
Apr 251000
May 255000
Jun 252000
Jul 250000
Aug 250000
Sep 251000
Oct 252000
Nov 251000
Dec 253000
Jan 264000
Feb 260000
Mar 260000
Apr 261000
May 263000
Jun 261000
Jul 262000
Aug 261000
Sep 260000
Oct 263000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

1 more in this ranking with a free account

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • High Test Results10
  • Low Test Results9
  • Non Reproducible Results9

2 more in this ranking with a free account

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions19

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Tosoh Bioscience Inc

    Z-2066-2018 · Started Mar 5, 2018

    Reason given: Asfotase Alfa (Strensiq) interferes with certain Tosoh assays which potentially causes falsely increased or falsely decreased immunoassay test results, depending upon the assay.

    Cause as FDA categorized it: Device Design

  • Siemens Healthcare Diagnostics, Inc.

    Z-1678-2018 · Started Jan 2, 2018 · Posted by FDA May 4, 2018

    Reason given: Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA,...

    Cause as FDA categorized it: Error in labeling

  • Siemens Healthcare Diagnostics, Inc.

    Z-1679-2018 · Started Jan 2, 2018 · Posted by FDA May 4, 2018

    Reason given: Concentrations for the level of biotin that does not interfere is not currently listed in the instruction for use for the Dimension Vista CTNI, Dimension Vista MMB, Dimension Sirolimus, ADVIA Centaur FOL, ADVIA Centaur aHBcM and the following IMMULITE assays, 3gAllergy Specific IgE, anti-HBc, BR-MA (CA15-3), CEA,...

    Cause as FDA categorized it: Error in labeling

6 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.